Danhong injection enhances the therapeutic efficacy of mesenchymal stem cells in myocardial infarction by promoting angiogenesis
Stem cell-based therapies have the potential to dramatically transform the treatment and prognosis of myocardial infarction (MI), and mesenchymal stem cells (MSCs) have been suggested as a promising cell population to ameliorate the heart remodeling in post-MI. However, poor implantation and surviva...
Main Authors: | Chen, J, Wei, J, Huang, Y, Ma, Y, Ni, J, Li, M, Zhu, Y, Gao, X, Fan, G |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Frontiers Research Foundation
2018
|
Similar Items
-
Mesenchymal stem cells regulate angiogenesis according to their mechanical environment.
by: Kasper, G, et al.
Published: (2007) -
Angiogenesis in the infarcted myocardium.
by: Cochain, C, et al.
Published: (2013) -
RNA therapeutics – The potential treatment for myocardial infarction
by: Chu, Hunghao, et al.
Published: (2021) -
Stem cell treatment for acute myocardial infarction.
by: Clifford, D, et al.
Published: (2012) -
Stem cell treatment for acute myocardial infarction.
by: Martin-Rendon, E, et al.
Published: (2008)